Islamabad, July 6, 2023 – The Drug Regulatory Authority of Pakistan (DRAP) has issued a warning to pharmaceutical companies that are failing to print barcodes on the packaging of their products.
(more…)Tag: DRAP
-
AGP asked to conduct special audit of DRAP
ISLAMABAD: Auditor General of Pakistan (AGP) has been asked to conduct special audit of Drug Regulatory Authority of Pakistan (DRAP) for past five fiscal years.
On the directives of Aamer Mehmood Kiani, Federal Minister for National Health Services, the health ministry had written a letter to AGP and requested to conduct the special audit of DRAP for the fiscal years 2012-2013 to 2017-2018, a statement said on Saturday.
According to letter DRAP was established through DRAP Act promulgated on November 13, 2012.
The Authority is mandated to regulate Allopathic, Homoeopathic, Unani and Herbal drugs, medical devices, medicated cosmetics etc.
In view of its role that has a direct impact on the health and wellbeing of the people, the authority remains a subject of public scrutiny.
DRAP receives continued media attention alleging irregularities and malpractices regarding diverse areas being dealt by the authority as per its mandate.
It goes without saying that transparency and efficiency in functioning of the organization is of critical importance to meet the targets and ensure sustained availability of quality medicines to the masses.
In view of the foregoing, to further instill public confidence in the authority, it is requested to conduct a Special Audit of DRAP for the period 2012-2013 to-date of the Pricing Mechanism to ascertain whether prices of drugs are determined justly, in accordance with the laid down policy and as per law.
-
GlaxoSmithkline’s drugs seized for illegal price increase
ISLAMABAD: Federal Minster Aamer Mehmood Kiani and Chief Executive Officer (CEO) Drug Regulatory Authority of Pakistan (DRAP) Asim Rauf visited UDL distribution along with area Federal Inspector of Drugs.
“Stock of GlaxoSmithkline was seized on unauthorized increase in the price,” said a statement on Thursday.
In continuation of the crackdown against companies for unauthorized increase in the prices of their medicines, DRAP has been directed to take strict action by Federal Minister of Health.
Across the country, inspectors of DRAP are involved in active surveillance.
Various medicines were seized in Lahore, Karachi, Islamabad, Faisalabad and Peshawar.
Stock of overpriced medicine seized in Faisalabad from IBL distribution. Around 39 medicines with unauthorized increase in pricing were seized from various pharmacies in Lahore.
Karachi’s MM traders raided by Federal Inspector of Drugs. Huge stock of overpriced medicine seized. Action against unauthorized increase in prices of medicines:
DRAP seized stocks from various medical stores in Peshawar.
Balouch enterprises raided in Multan: seizure of stock of overpriced medicine.
Federal Minister said that legal action will be taken against those involved in unauthorized increase in prices of medicine.
He added that reduction in prices of 395 prices was notified and strict compliance of the companies shall be ensured.
The crackdown will continue against those companies who are not selling medicine on approved prices.
-
DRAP warns pharma industry against increasing drug prices
ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has taken notice of unauthorized increase in prices of medicines.
In this regard the authority issued directives to pharmaceutical industries asking them to ensure maximum retail price (MRP).
“Your are advised to monitor MRPs in the market and ensure that MRPs of drugs are not higher than the prices notified through SRO 1610(I)/2018 dated December 31, 2018.”
In case of stocks available in the retail shops or manufactured/imported prior to issuance of this above said SROs must be sold at previous MRPs printed on the label in the manner prescribed by the Drugs (Labeling and Packing) Rules, 1986 and stickers/ cuttings are not allowed.
The authority said that some complaints had been received that unscrupulous elements in the pharma industry had increased prices of their drugs over and above approved maximum retail prices by the federal government.
In recent past MRPs of 889 drugs were notified after approval by the federal government through SRO 1610(I)/2018 dated December 31, 2018.
In addition an increase at 9 percent over and above the notified prices was allowed on January 10, 2019. Besides, another 15 percent increase was allowed on the same date in case of several other drugs.
The authorities said that in case of non-compliance by pharma industry, legal action would be taken against violators under the Drugs Act, 1976, DRAP Act, 2012 and rules framed three under and SRO 913 dated September 09, 2019.
-
DRAP notifies up to 15 percent increase in medicine retail prices
ISLAMABAD – The Drug Regulatory Authority of Pakistan (DRAP) has issued a notification announcing an increase in the maximum retail prices of medicines by up to 15 percent.
(more…)